Get complete Patent Opposition Report for Ads Therapeutics

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Ads Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3463315Jun 14, 2023Compositions And Methods Of Using Nintedanib For Treating Ocular Diseases With Abnormal Neovascularization1